| Allarity Therapeutics Announces the Grant of Essential U.S. Patent for Its Stenoparib DRP® Companion Diagnostic |
Globe Newswire |
06/30 |
08:00 |
| Quince Therapeutics Appoints Recognized Leaders in Pulmonary Medicine to Scientific Advisory Board |
Globe Newswire |
06/30 |
08:00 |
| MediciNova CEO Provides Shareholder Update |
Globe Newswire |
06/30 |
08:00 |
| Innventure Announces Appointment of Dr. Bill Grieco as CEO following Retirement of Current CEO Bill Haskell |
Globe Newswire |
06/30 |
08:00 |
| KashKick Survey Reveals Mobile Gaming as a Daily Habit and Income Source for Americans |
Globe Newswire |
06/30 |
08:00 |
| American Lithium Minerals, Inc. (OTC: AMLM) Acquires 100% Interest in High Grade New Zealand Gold–Antimony Projects |
Globe Newswire |
06/30 |
08:00 |
| ALX Oncology Appoints Scott Garland as Chairman of the Board and Michael Listgarten as General Counsel |
Globe Newswire |
06/30 |
08:00 |
| CapEx Finance Index May 2026: Demand Cools, But Remains Healthy |
Globe Newswire |
06/30 |
08:00 |
| First Orion Awarded 2026 Visionary Spotlight Award for Business Technology by ChannelVision Magazine |
Globe Newswire |
06/30 |
08:00 |
| Upexi Partners with Blueprint to Stake Solana Treasury Assets |
Globe Newswire |
06/30 |
08:00 |
| Lands’ End Announces CEO Transition, Positioning Company for Next Phase of Growth |
Globe Newswire |
06/30 |
08:00 |
| Cogent Biosciences Announces Submission of New Drug Application (NDA) for Bezuclastinib in Advanced Systemic Mastocytosis (AdvSM) |
Globe Newswire |
06/30 |
08:00 |
| Kneat Files Management Information Circular in Connection with the Previously Announced Thoma Bravo Transaction |
Globe Newswire |
06/30 |
07:57 |
| Eos Announces $125 Million Investment for Frontier Power USA, Bringing Expected Frontier Equity Investment up to $375 Million |
Globe Newswire |
06/30 |
07:55 |
| Eos Energy Announces Updated Terms for Rights Offering |
Globe Newswire |
06/30 |
07:50 |
| ZenaTech Reports Annualized Revenue Run Rate of Approximately CAD $33 Million Based on First Quarter 2026 Revenue |
Globe Newswire |
06/30 |
07:45 |
| Eos Announces Pricing of Registered Direct Offering of Common Stock and Warrants to Fund Investment in Frontier Power USA |
Globe Newswire |
06/30 |
07:45 |
| FocalTherics™ Announces Successful Launch of First Commercial Endometriosis Focal One® Program in Europe with Treatment of Initial Patients |
Globe Newswire |
06/30 |
07:30 |
| One Bullion Announces Board Transition |
Globe Newswire |
06/30 |
07:30 |
| Palvella Therapeutics Appoints Accomplished Rare Disease Biotech Executive and Commercial Leader Matt Pauls, J.D., M.B.A., to Board of Directors |
Globe Newswire |
06/30 |
07:30 |
| Plus Therapeutics Provides Mid-Year Business Update Including Corporate Rebranding |
Globe Newswire |
06/30 |
07:30 |
| Blockfusion and Blue Acquisition Corp. Announce LOIs for Anchor Lease with a Leading AI Customer and $175 Million Convertible Note Financing and Non-Redemption Agreement, and Advancement of Planned Expansion of Niagara Falls Campus |
Globe Newswire |
06/30 |
07:30 |
| OptimizeRx Launches CopayCue™, a Next-Generation Copay Activation Solution Powered by Real-Time Prescribing Intent |
Globe Newswire |
06/30 |
07:30 |
| Pacira BioSciences Announces Agreement to Divest its iovera° Business to Zimmer Biomet |
Globe Newswire |
06/30 |
07:30 |
| Pyxis Oncology Announces Up to $114 Million Private Placement Financing to Advance MICVO Through Key Clinical Milestones |
Globe Newswire |
06/30 |
07:30 |
